Signaling by soluble Triggering Receptor Expressed on Myeloid Cells 2 (sTREM2) and its ligand transgelin-2 (TG2) is a newly described pathway that plays a critical role in AD pathogenesis [9]. The gene discussed is TAGLN2; the disease is Alzheimer disease.